Product Program year 2025 Source: CMS Open Payments

Anzupgo

Drug Dermatology

NDC 50222-280-30

Open in the dashboard

General payments

$2,370,304

17,436 payments

Research payments

$74,399

1 payment

Through program year 2025, $2,370,304 in general payments and $74,399 in research payments were reported against Anzupgo (Dermatology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $2,370,304 17,436
2025 Research $74,399 1

Breakdown

Who paid General payments · program year 2025
  1. LEO Pharma Inc. $2,357,751 17,430 payments
  2. LEO Pharma AS $12,553 6 payments
Top recipients General payments · program year 2025
  1. Maureen Offiah Dermatology · Hattiesburg, MS $77,691 3% · 65 payments
  2. Omar Noor Somerset, NJ $61,443 3% · 46 payments
  3. James Del Rosso MOHS-Micrographic Surgery · Las Vegas, NV $58,002 2% · 31 payments
  4. Naiem Issa Dermatology · Vienna, VA $56,682 2% · 67 payments
  5. Firas Hougeir Dermatology · Douglasville, GA $52,064 2% · 39 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Dermatology $1,526,105 67% · 2,872 practitioners
  2. Physician Assistant $261,921 11% · 2,089 practitioners
  3. MOHS-Micrographic Surgery Dermatology $163,939 7% · 215 practitioners
  4. Physician Assistant, Medical Physician Assistant $125,507 5% · 590 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $42,050 2% · 655 practitioners

The top 5 of 75 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $235,712 10% · 764 recipients
  2. California $229,373 10% · 923 recipients
  3. Texas $167,381 7% · 551 recipients
  4. Florida $152,174 6% · 523 recipients
  5. Nevada $142,351 6% · 113 recipients

The top 5 of 50 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

17,436 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record